Authors:
Bochner, B
Burke, R
Colman, S
Fontana, L
Gerard, D
Gersten, M
Papazian, E
Polanis, S
Stammer, B
Turnbull, K
Voorhies, K
Wolsfeld, D
Allingham, D
Bloome, G
Chartier, G
Clausen, T
Dore, G
Gannavaram, S
Lieberman, B
Lindley, J
Zarrillo, M
Citation: B. Bochner et al., Smart growth? Sensible growth? Sustainable growth? Balanced growth? ... Responsible growth - What are the transportation needs to achieve this growth?, ITE J, 70(4), 2000, pp. 28-31
Authors:
Chavan, SJ
Tamma, SL
Kaplan, M
Gersten, M
Pahwa, SG
Citation: Sj. Chavan et al., Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy, CLIN IMMUNO, 93(1), 1999, pp. 24-33
Authors:
Krogstad, P
Wiznia, A
Luzuriaga, K
Dankner, W
Nielsen, K
Gersten, M
Kerr, B
Hendricks, A
Boczany, B
Rosenberg, M
Jung, D
Spector, SA
Bryson, Y
Citation: P. Krogstad et al., Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate, CLIN INF D, 28(5), 1999, pp. 1109-1118
Authors:
Starr, SE
Fletcher, CV
Spector, SA
Yong, FH
Fenton, T
Brundage, RC
Manion, D
Ruiz, NM
Gersten, M
Becker, M
McNamara, J
Mofenson, LM
Citation: Se. Starr et al., Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1, N ENG J MED, 341(25), 1999, pp. 1874-1881